| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/2011 | WO2011105975A1 Dry powder formulations administered by the inhalation route comprising a combination of tiotropium bromide, salmeterol xynafoate and fluticasone propionate. |
| 09/01/2011 | WO2011105963A1 Photosensitizer-containing composition |
| 09/01/2011 | WO2011105912A1 Improved calcium formulation |
| 09/01/2011 | WO2011105825A2 Resveratrol effective in treating and preventing prion diseases |
| 09/01/2011 | WO2011105658A1 Cell protectants comprising placenta extracts |
| 09/01/2011 | WO2011105649A1 New method for manufacturing pitavastatin hemicalcium using new intermediate |
| 09/01/2011 | WO2011105643A1 Selenalzole derivative having ligand which activates peroxisome proliferator activated receptor (ppar), preparing method thereof and usage of the chemical compounds |
| 09/01/2011 | WO2011105633A1 Virus-inactivating composition containing low-molecular weight compound and arginine |
| 09/01/2011 | WO2011105628A1 Pyrazolopyrimidine compounds and their use as pde10 inhibitors |
| 09/01/2011 | WO2011105611A1 Ghrelin receptor agonist for treatment of dyscrasia |
| 09/01/2011 | WO2011105590A1 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor |
| 09/01/2011 | WO2011105572A1 Novel heteroaryl derivative |
| 09/01/2011 | WO2011105568A1 Dried plant tissue and plant tissue extract for ameliorating central nervous system degenerative diseases accompanied by learning/memory disorders, movement disorders and the like, and pharmaceutical agent and food or beverage each comprising the dried plant tissue and the plant tissue extract |
| 09/01/2011 | WO2011105551A1 Method for detection of cancer stem cell, and therapeutic agent or recurrence-preventing agent for cancer |
| 09/01/2011 | WO2011105539A1 Coated solid preparation |
| 09/01/2011 | WO2011105520A1 Composite body for antigen or drug delivery |
| 09/01/2011 | WO2011105486A1 Adhesive patch |
| 09/01/2011 | WO2011105465A1 MAILLARD REACTION INHIBITOR, α-DICARBONYL COMPOUND DECOMPOSING AGENT, AND METHOD FOR INHIBITING THE MAILLARD REACTION |
| 09/01/2011 | WO2011105458A1 Adhesive patch containing bisoprolol |
| 09/01/2011 | WO2011105431A1 Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage |
| 09/01/2011 | WO2011105424A1 Dendritic cell immunoreceptor stimulant |
| 09/01/2011 | WO2011105402A1 Short-chain cationic polyamino acid and use thereof |
| 09/01/2011 | WO2011105099A1 Compound containing a novel 4-alkoxypyridine formation and medicine containing same |
| 09/01/2011 | WO2011104981A1 Eye drops for treating eye infection containing levofloxacin, salt thereof or solvate of same, method for treating eye infection, levofloxacin, salt thereof or solvate of same, and utilization thereof |
| 09/01/2011 | WO2011104901A1 Anti-trichophyton agent, therapeutic material for skin diseases caused by trichophyton bacterium which comprises same, and therapeutic tool for the diseases |
| 09/01/2011 | WO2011104900A1 Anti-fungal agent |
| 09/01/2011 | WO2011104680A1 Oxadiazole compounds, their preparation and use |
| 09/01/2011 | WO2011104671A1 Novel water soluble furoxan derivatives having antitumor activity |
| 09/01/2011 | WO2011104652A2 Veterinary compositions |
| 09/01/2011 | WO2011104631A1 Sn-38 compositions |
| 09/01/2011 | WO2011104625A1 Cyclopolysaccharide compositions |
| 09/01/2011 | WO2011104621A1 Surfactant composition |
| 09/01/2011 | WO2011104584A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders |
| 09/01/2011 | WO2011104568A1 Treatment of oxidative stress disorders |
| 09/01/2011 | WO2011104562A1 Fungal nail treatment composition |
| 09/01/2011 | WO2011104560A1 Diet and methods for improving learning capacity, mood and behavior in mammals |
| 09/01/2011 | WO2011104515A1 Products and methods |
| 09/01/2011 | WO2011104490A2 Use of essential oil of oregano and of rosewood, or constituents thereof, in the therapeutic treatment of keratoses |
| 09/01/2011 | WO2011104489A2 Use of essential oil of oregano or of rosewood, or constituents thereof, in the cosmetic treatment of keratoses |
| 09/01/2011 | WO2011104409A1 Platinum complexes with trans geometry, comprising a sulphonamide ligand with antitumour activity |
| 09/01/2011 | WO2011104360A1 Formulation of compositions for the treatment of inflammatory conditions |
| 09/01/2011 | WO2011104340A1 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 09/01/2011 | WO2011104338A1 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | WO2011104337A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | WO2011104334A1 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | WO2011104322A1 Bisaryl-bonded aryltriazolones and use thereof |
| 09/01/2011 | WO2011104298A1 Prevention and treatment of diseases caused by elevated levels of deoxy-sphingolipids |
| 09/01/2011 | WO2011104275A1 Formulations for oral delivery of adsorbents in the gut |
| 09/01/2011 | WO2011104266A1 Dimeric iap inhibitors |
| 09/01/2011 | WO2011104215A1 Biodegradable material containing silicon, for pro-angiogenetic therapy |
| 09/01/2011 | WO2011104214A1 Silicon-containing biodegradable material for anti-inflammatory therapy |
| 09/01/2011 | WO2011104203A1 Compounds as bradykinin b1 antagonists |
| 09/01/2011 | WO2011104169A1 Compositions for targeted delivery of sirna |
| 09/01/2011 | WO2011104161A1 Combination of a centrally-acting analgesic and a selective cyclooxygenase - 2 inhibitor anti - inflammatory agent for the treatment of inflammation and pain in the veterinary field |
| 09/01/2011 | WO2011103920A2 Pharmaceutical or neutraceutical formulation |
| 09/01/2011 | WO2011103806A1 Oral microemulsion of elemene |
| 09/01/2011 | WO2011103789A1 Capsule of complex danshen drop pill |
| 09/01/2011 | WO2011103788A1 (±)-marinopyrrole a and synthesized derivatives thereof for resisting methicillin-resistant staphylococcus aureus |
| 09/01/2011 | WO2011103774A1 Pharmaceutical composition and use thereof in manufacturing medicaments for treating respiratory diseases |
| 09/01/2011 | WO2011103773A1 Pegylated cyclopamine analogue, preparation method and uses thereof |
| 09/01/2011 | WO2011103718A1 Controlled (sustained) release preparation containing quetiapine and preparation method and use thereof |
| 09/01/2011 | WO2011103715A1 Task channel antagonists |
| 09/01/2011 | WO2011103686A1 CEPHALOSPORIN DERIVATIVES USEFUL AS β-LACTAMASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF |
| 09/01/2011 | WO2011103648A1 Method for preparing ointments containing antioxidants from polyphenol-rich plants for use in the treatment of wounds of various origins which involve an increase in oxidation-promoting agents and/or increased formation of oxygen-derived reactive species and/or reduced formation of nitric oxide |
| 09/01/2011 | WO2011085129A3 Methods and compositions of targeted drug development |
| 09/01/2011 | WO2011084548A8 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 09/01/2011 | WO2011076367A3 Synergistic antiviral composition and use thereof |
| 09/01/2011 | WO2011070177A3 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 09/01/2011 | WO2011068303A3 Hyaluronic acid derivative effective against atopic dermatitis, and method for manufacturing same |
| 09/01/2011 | WO2011065831A3 Improved formulations comprising heteropolysaccharides |
| 09/01/2011 | WO2011061616A3 Extended release compositions containing tolterodine and process for preparing the same |
| 09/01/2011 | WO2011059931A9 Nanosuspension of a poorly soluble drug made by microfluidization process |
| 09/01/2011 | WO2011059866A3 Composition and methods for improving skin appearance |
| 09/01/2011 | WO2011056650A9 Methods and compositions for treating and preventing viral infections |
| 09/01/2011 | WO2011052888A3 (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition containing same as active ingredients for the diagnosis or treatment of neurodegenerative brain diseases |
| 09/01/2011 | WO2011049988A3 Indazoles to treat flaviviridae virus infection |
| 09/01/2011 | WO2011046978A3 Steroidal compounds as melanogenesis modifiers and uses thereof |
| 09/01/2011 | WO2011041639A3 Heteroatom containing substituted fatty acids |
| 09/01/2011 | WO2011034396A3 Solid dispersion comprising a fibrate drug, and method for preparing the solid dispersion |
| 09/01/2011 | WO2011034362A3 Composition containing saururus chinensis extract or sauchinone as an active ingredient, for preventing and treating diseases caused by the overexpression of lxr-α |
| 09/01/2011 | WO2011027249A3 Benzimidazole derivatives |
| 09/01/2011 | WO2011017554A4 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
| 09/01/2011 | WO2011015882A3 Anhydrate of triotropium bromide |
| 09/01/2011 | WO2011007136A3 Process for the preparation of o-desmethyl venlafaxine and intermediate for use therein |
| 09/01/2011 | WO2010147792A3 Compounds which selectively modulate the cb2 receptor |
| 09/01/2011 | WO2010141550A3 11beta-hydroxysteroid dehydrogenase type 1 (11-beta hsd1) inhibitors |
| 09/01/2011 | WO2010139660A3 Ginger compositions |
| 09/01/2011 | WO2010132352A3 Spiro compounds and their use as therapeutic agents |
| 09/01/2011 | WO2010127195A3 Treatment of hemoglobin (hbf/hbg) related diseases inhibition of natural antisense transcript to hbf/hbg |
| 09/01/2011 | WO2010119367A3 A medicinal cream made using hydrocortisone acetate and a process to make the same |
| 09/01/2011 | WO2010114982A3 Lyophilization cakes of proteasome inhibitors |
| 09/01/2011 | WO2010088842A8 Pharmaceutical compositions containing pyridyl cyanoguanidines, preparation methods and uses thereof |
| 09/01/2011 | WO2010088350A3 Personal care article for sequentially dispensing compositions with variable concentrations of hydrophobic benefit materials |
| 09/01/2011 | WO2010083537A8 Optimal biological marker for the biological potency of emblica officinalis gaertn. (amla) fruit-methods and products thereof |
| 09/01/2011 | WO2006039763A8 Vitamin d3 analogues for the prevention and treatment of bone disorders |
| 09/01/2011 | US20110214195 Methods For Treating Clinical Conditions Associated With Lipoprotein Lipase Activity |
| 09/01/2011 | US20110214194 Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway |
| 09/01/2011 | US20110214192 Photoconvertible fluorescent proteins |
| 09/01/2011 | US20110213337 Methods for the early diagnosis of ovarian cancer |
| 09/01/2011 | US20110213147 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |